Implementation of High-Sensitivity and Point-of-Care Cardiac Troponin Assays into Practice: Some Different Thoughts

Area of Science:

• Clinical Chemistry
• Cardiovascular Diagnostics
• Biomarker Assay Development

Background:

• The International Federation of Clinical Chemistry (IFCC) Committee on Clinical Application of Cardiac Bio-Markers (C-CB) focuses on educating users about cardiac biomarker applications.
• Emphasis is placed on the clinical utility and implementation of high-sensitivity cardiac troponin assays.

Purpose of the Study:

• To review new IFCC C-CB/AACC Academy laboratory practice recommendations for cardiac troponin assays.
• To discuss updated concepts from the Fourth Universal Definition of Myocardial Infarction.
• To explore the role and regulatory challenges of point-of-care (POC) troponin assays in clinical practice and research, including considerations during the COVID-19 pandemic.

Main Methods:

• Mini-review of current literature and guidelines.
• Analysis of recent recommendations and definitions.
• Discussion of practical and regulatory aspects of POC troponin assays.

Main Results:

• High-sensitivity cardiac troponin assays significantly impact current and future clinical practice and research.
• POC high-sensitivity cardiac troponin assays have the potential to enhance patient management.
• Timely regulatory clearance of POC assays is essential for widespread adoption and improved patient outcomes.

Conclusions:

• The implementation of high-sensitivity cardiac troponin assays represents a significant advancement in cardiovascular diagnostics.
• Optimizing the development and regulatory pathways for POC troponin assays is critical.
• These advancements promise to improve patient care and clinical decision-making in myocardial infarction diagnosis and management.